PTH Among Health Care ETFs
End-of-day Nov 18, 2026 · 39 Health care ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −8.0% | −6.6% | −11.5% | +10.6% | +12.9% | +83.0% | +5.4% | +271.0% | +583.8% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$43 of every $1,000 in PTH is Roivant
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ROIVRoivant Sciences | Healthcare | 4.29% | $429.09 | 301K | $11.7M |
| 2 | THCTenet Healthcare | Healthcare | 4.22% | $422.50 | 41K | $11.5M |
| 3 | INSMInsmed | Healthcare | 4.16% | $416.09 | 93K | $11.3M |
| 4 | GHGuardant Health | Healthcare | 3.37% | $336.76 | 64K | $9.1M |
| 5 | RVMDRevolution Medicines | Healthcare | 3.29% | $328.88 | 55K | $8.9M |
| 6 | AXGNAxogen | Healthcare | 3.25% | $325.30 | 160K | $8.8M |
| 7 | MEDPMedpace | Healthcare | 3.16% | $315.87 | 13K | $8.6M |
| 8 | HNGEHinge Health | Healthcare | 3.00% | $299.70 | 71K | $8.1M |
| 9 | TXG10X Genomics | Healthcare | 2.96% | $296.47 | 143K | $8.1M |
| 10 | EXELExelixis | Healthcare | 2.96% | $295.67 | 117K | $8.0M |
| 11 | NTRANatera | Healthcare | 2.88% | $287.56 | 27K | $7.8M |
| 12 | IOVAIovance Biotherapeutics | Healthcare | 2.76% | $276.17 | 996K | $7.5M |
| 13 | CDNACareDx | Healthcare | 2.52% | $252.21 | 92K | $6.8M |
| 14 | CRLCharles River Laboratories International | Healthcare | 2.48% | $248.13 | 20K | $6.7M |
| 15 | PACSPACS Group | Healthcare | 2.39% | $239.21 | 134K | $6.5M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ROIV | Roivant Sciences | 4.29% |
| 2 | THC | Tenet Healthcare | 4.22% |
| 3 | INSM | Insmed | 4.16% |
| 4 | GH | Guardant Health | 3.37% |
| 5 | RVMD | Revolution Medicines | 3.29% |
| 6 | AXGN | Axogen | 3.25% |
| 7 | MEDP | Medpace | 3.16% |
| 8 | HNGE | Hinge Health | 3.00% |
| 9 | TXG | 10X Genomics | 2.96% |
| 10 | EXEL | Exelixis | 2.96% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 26, 2025 | $1.53 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0255 |
| Dec 20, 2013 | Dec 31, 2013 | $0.0114 |
| Sep 20, 2013 | Sep 30, 2013 | $0.0027 |
| Jun 21, 2013 | Jun 28, 2013 | $0.0368 |
| Dec 21, 2012 | Dec 31, 2012 | $0.11 |
| Jun 15, 2012 | Jun 29, 2012 | $0.0084 |
| Dec 18, 2009 | Dec 31, 2009 | $0.0194 |
| Jun 19, 2009 | Jun 30, 2009 | $0.0083 |